Clinical Trial Update: Safety Study of Autologous Cultured Adipose -Derived Stem Cells for the Fecal Incontinence [Phase 1]

View source ↗

Summary

Phase 1 safety study evaluating autologous cultured adipose-derived stem cells for fecal incontinence was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fecal Incontinence

Drugs mentioned

• Autologous Cultured Adipose-Derived Stem Cells (adipose-derived stem cells (autologous, cultured))

Snippet

Sponsor: Anterogen Co., Ltd. | Conditions: Fecal Incontinence | Phase 1 | Status: TERMINATED